Logo
x

Search category

Subscribe Now

Complicated Intra-Abdominal Infections

Tetraphase Pharmaceuticals' Xerava (eravacycline) Receives FDA's Approval for Complicated Intra-Abdominal Infections (CIAI)

Tetraphase Pharmaceuticals' Xerava (eravacycline) Receives FDA's Approval for Complicated Intra-Abdominal Infections (CIAI)

  • August 27, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.